551 related articles for article (PubMed ID: 19076171)
21. Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis.
Hemmer PR; Topazian MD; Gertz MA; Abraham SC
Am J Surg Pathol; 2007 Jan; 31(1):141-5. PubMed ID: 17197930
[TBL] [Abstract][Full Text] [Related]
22. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
23. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
26. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
27. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
[TBL] [Abstract][Full Text] [Related]
28. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
[TBL] [Abstract][Full Text] [Related]
29. Systemic immunoglobulin light-chain amyloidosis.
Comenzo RL
Clin Lymphoma Myeloma; 2006 Nov; 7(3):182-5. PubMed ID: 17229332
[TBL] [Abstract][Full Text] [Related]
30. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
[TBL] [Abstract][Full Text] [Related]
31. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
32. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.
Olsen KE; Sletten K; Westermark P
Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180
[TBL] [Abstract][Full Text] [Related]
33. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
34. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
[TBL] [Abstract][Full Text] [Related]
37. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
Olsen KE; Sletten K; Westermark P
Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
[TBL] [Abstract][Full Text] [Related]
38. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis].
Katayama Y; Sakai A; Nobuyoshi M; Shimomura T; Kimura A
Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983
[TBL] [Abstract][Full Text] [Related]
39. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
40. [Amyloidosis].
Franklin EC
Fortschr Med; 1977 May; 95(20):1329-32. PubMed ID: 406184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
